Cassava Sciences Other Equity Adjustments (Quarterly) Analysis

Cassava Sciences, Inc. (SAVA)

2.29 -0.16 (-6.53%) USD | NASDAQ | Feb 25, 15:02

View Other Equity Adjustments (Quarterly) for SAVA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Equity Adjustments (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Equity Adjustments (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Equity Adjustments (Quarterly) Benchmarks

Start Trial

cbdMD, Inc.	--
BioMarin Pharmaceutical, Inc.	Upgrade
Amicus Therapeutics, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Ovid Therapeutics, Inc.	Upgrade